Oruka Therapeutics, Inc. ORKA Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s total liabilities?
- Oruka Therapeutics, Inc. (ORKA) reported total liabilities of $17.76M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s total liabilities changed year-over-year?
- Oruka Therapeutics, Inc.'s total liabilities increased by 43.4% year-over-year, from $12.39M to $17.76M.
- What is the long-term trend for Oruka Therapeutics, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Oruka Therapeutics, Inc.'s total liabilities has grown at a 33.7% compound annual growth rate (CAGR), from $3.91M to $16.69M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.